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Abstract
Introduction: Preeclampsia-eclampsia has been one of the main cause of maternal morbidity-mortality in developing countries,
affecting 10% of pregnancies. In Mexico, in the recent years it has been estimated at about 2 to 35 new cases per 100
pregnancies.
Objective: To report the evolution and severity of blood pressure and proteinuria; and their repercussion on renal function after
delivery, in patients who developed preeclampsia.
Methods: It was a descriptive analysis of 24 preeclamptic women on clinical follow up until normalization of blood pressure.
Results: We observed lower serum albumin, higher severity of 24 hrs proteinuria level and longer duration of hypertension in
those women who presented with the highest levels in diastolic blood pressure at the beginning and end of the study.
Name of the department and institution or hospital where the
work was done: National Medical Center “20 de
Noviembre”, ISSSTE, Mexico, City.
INTRODUCTION
Preeclampsia-eclampsia has one of the main cause of
maternal morbidity and mortality in developing countries. It
occurs in about 12-22% of pregnancies depending on the
population and the definitions used, with unfavorable impact
on maternal and perinatal health as it predisposes toward
potentially lethal complications involving placental
abruption, disseminated intravascular coagulation,
hypertensive encephalopathy, intracranial hemorrhage, lung
edema, hepatic failure, acute renal failure and cardiovascular
collapse (1,2,3). It is important to note that although mortality
rates in developed countries are low, strategies for its
prevention and treatment still received growing attention,
due among other reasons, like cost-benefit considerations (3).
In Mexico, in the recent years it has been estimated at about
2 to 35 new cases per 100 pregnancies (4), and was the first
leading cause of maternal death in the National Health
Service, Mexico (5). The medical literature review on the
topic reveals an increased interest in the research directed to
clarify the etiology and pathogenesis. There are many
theories among which the major focus are the placenta as the
cause of ischemic disturbances due to poor immunologic
adaptation, genetic predisposition and secretion of vascular
factors that cause placental endothelium morphological
changes (6), the presence of von Willebrand factor,
endothelin, prostacycline, thromboxane, and balance
disturbance between the tissular plasminogen activator and
inhibitor, favoring the increment of platelet aggregation and
vasoconstriction (7).
In preeclampsia, the principal renal histopathological
alteration is glomerular endotheliosis, described as
hypertrophy and edema of capillary cells by glomerular
ischaemia, that causes decrease of blood flow and
glomerular filtrate (8,9).
Clinically hypertensive disease of the pregnancy has been
classified by the World Health Organization, American
College of Gynecology and Obstetrics, International Society
for the Study of Hypertension, and by National Education
Program Working Group on High Blood Pressure in
Pregnancy, with this last one being the most accepted, and
described as follows: (10,11):
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Preeclampsia:Systolic blood pressure > 140 mm Hg or
diastolic blood pressure > 90 mm Hg on at least 2 occasions,
4 hours to 1 week apart, proteinuria (>300 mg in a 24-hour
urine collection), and edema after the twentieth week of
gestation.
Eclampsia:Generalized seizures in a preeclamptic pregnant
woman.
Chronic arterial hypertension:Arterial hypertension before
pregnancy.
Chronic arterial hypertension with preeclampsia: The
combination of arterial hypertension and preeclampsia.
Gestational hypertension:Increment of arterial tension
without being accompanied of proteinuria after the twentieth
week of gestation. If it is resolved in the period of 12 weeks
postpartum is called transitory gestational hypertension.
Efforts to recognize early this diagnosis in women with high
risk to develop preeclampsia-eclampsia, is a concern for the
obstetrician, because every woman in gravid state could
suffer it, with higher incidence in those that have specific
characteristics such as primiparity, multiple pregnancies,
extreme ages and patients with diseases like diabetes
mellitus and nephropathy as has been demonstrated in
observational and epidemiological studies (12), but
unfortunately the precipitating factors are still unknown. In
spite of the advances in therapeutic outlines and its
application, morbi-mortality rates have not been decreased
(13,14); with certainty later repercussions in medium and long
time. Arterial hypertension is a risk factor for accelerated
atheroesclerosis (15), as well as proteinuria as fact of renal
damage; duration and intensity of these rebounds in renal
function after childbirth in those women who suffered from
preeclampsia-eclampsia.
Published studies of patients with severe preeclampsia-
eclampsia point out the risk of recurrence in subsequent
pregnancies, as well as the increment in the probability to
present chronic arterial hypertension (1).
The aim of this study was to know the evolution and
intensity of arterial pressure and proteinuria and its
repercussion in renal function after childbirth, in patients
who developed preeclampsia.
MATERIAL AND METHODS
It was carried out as a descriptive analysis of 24 pregnant
women that presented preeclampsia according to the
definition by the American College of Gynecology and
Obstetrics. They were managed at the perinatology service
of the National Medical Center “20 de Noviembre”, ISSSTE,
Mexico, City, and followed up in the Clinic of Hypertension,
from January to August 2002.
Complete clinical history, and laboratory exams such as
hematic biometry, glucose, creatinine, urea, electrolytes,
hepatic function tests, serum albumin, 24 hrs creatinine
clearance, and proteinuria in 24 hrs were made, at the
beginning and follow up of the study. Antihypertensive
treatment on discharging from the perinatology service was
implemented with metoprolol, captopril and nifedipine that
were replaced by amlodipine and enalapril, when the former
ones were in maximum doses. Doses of these drugs were
modified depending on the clinical evolution. When the
diastolic arterial pressure was of 90 mm Hg or lower,
determined in two or more occasions, treatment was
suspended. The 24 hr urine proteinuria was evaluated
periodically until negative. Creatinine clearance was
evaluated until arterial pressure control without drugs.
Statistical analysis was performed using the SPSS10
program.
RESULTS
During this six month period we registered 24 patients, three
of them were excluded because of antiphospholipid
syndrome, hypothyroidism and chronic arterial hypertension.
Cesarean section was performed on our 21 patients and their
general data were:
Mean age - 33 years (range 22– 42 years);
Gravidity (G) - GI:8 (38.09%), GII:7 (33.3%),
GIII:4 (19.04%), GIV:1(4.76%), GV:1 (4.76%);
Weeks of gestation when preeclampsia diagnosis was made -
mean 29.4 weeks (range 21-38 weeks), 4 in the period of
20-24 weeks (19.04%), 6 in 25-29 weeks (28.57%), 9 in
30-34 weeks (42.85%), and 2 in 35-39 weeks (9.52%) (Table
1).
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Figure 1
Table 1: Pregnancy information at the time of preeclampsia
diagnosis
Mean systolic blood pressure after patients underwent
cesarean section was of 151.9 mm Hg with diastolic blood
pressure of 99.05 mm Hg. At the end of the follow up period
the means were 116.71 and 75.95 mm Hg (70-100)
respectively, with a duration average of 79.5 days (20-224)
(Table 2 and Fig 1). Besides, 14 patients required an average
of 6.78 subsequent consults (with intervals of one month) to
control arterial pressure with drugs and later on other 5
before discharge from study. 7 patients (33.3%) were still on
antihypertensive treatment at the end of our study, with a
mean follow up of 95.14 days (28-160).
Figure 2
Table 2: Arterial blood pressure and laboratory findings
Figure 3
Figure 1: Evolution of systolic arterial pressure
Mean creatinine clearance at delivery was of 96.9 ml/hr
(37.96-146.7), and at the end of the study was of 93.8 ml/hr
(30.73-164.7) (Table 2). One patient was included in
protocol study of renal hypertension because she presented
with more deterioration since delivery.
Initial mean proteinuria level was of 2.1 g/24 hr (0.5 - 6.1)
and the last one before negative status was 1.64 g/24 hr (0.26
- 8.75), with an average duration of 32.6 days (10-90). No
patient presented with proteinuria at the end of the study
(Table 2). Initial mean serum albumin was 2.08 mg/dl
(1.5-2.9) and final was 2.78 gr/dl (1.6-4.6) with a mean
duration of 32.6 days (10-90), coinciding its duration with
the 24 hr proteinuria (Table 2). Furthermore at the beginning
of the study there was no significative statistical relationship
between diastolic pressure and creatinine clearance but at the
end, increment of diastolic pressure correlated with
diminished albumin (Pearson correlation of –0.386).
Intensity of 24 hr proteinuria was higher in those women that
also had higher diastolic blood pressure at the beginning and
end. In addition we found a significant negative correlation
between creatinine clearance and serum creatinine (Pearson
of –0.474). Also there were negative correlations between
systolic blood pressure with serum creatinine and albumin
(Pearson of –0.207 and –0.358 respectively).
Duration of arterial hypertension was associated with the
higher intensity of diastolic blood pressure at the beginning
and end. Also, lower gestation showed higher increment in
final arterial blood pressure (p<0.01), higher intensity of
final 24 hr proteinuria (p<0.05) and longer duration of
hypertension (p<0.01). Finally, with younger age at
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preeclampsia diagnosis, longer duration of hypertension was
observed (p < 0.01).
DISCUSSION
In Mexico as in other countries, preeclampsia is more
frequent in primiparous women, 52% of all cases, and they
also have twice the risk of suffering from it in a subsequent
pregnancy (9). Preeclampsia is more frequent in patients
younger than 21 years of age and in older than 35. In our
study the mean age was of 33 years old.
The mean week of gestation when diagnosis was made was
of 29.4 weeks, higher than 25 weeks, reported by Siba (1).
However, we can appreciate that in the group of patients that
reached blood pressure control, creatinine clearance and
albumin were higher than in the group of no controlled
women; in addition, serum creatinine was lower in the first
one (Table 3). In any case there was no significative
statistical difference.
Figure 4
Table 3: Final values in controlled and not controlled
patients
Early beginning of preeclampsia in primigravida is an
important antecedent that is taken into account for maternal
and infantile long term morbi-mortality prognosis, because
of the repercussion in the severity of this disease (1), that we
have verified in our study. Nevertheless previous studies
does not consider the increase in arterial blood pressure and
proteinuria, that we suggest to be related with primiparity
and early beginning of preeclampsia, because of longer
duration of arterial hypertension after childbirth.
In our study, after childbirth, mean duration of hypertension
was of 79.5 days, higher than that reported by Ferrazzani et
al. (16) of 16 days, but their patients had younger gestational
age and less proteinuria. Unless, they did not correlate
changes in arterial blood pressure which is critical to
evaluate evolution and limit renal damage.
After pregnancy is finished, proteinuria commonly
disappears within 3 to 8 weeks, but occasionally persists for
months (17). Literature reports that in preeclampsia, both
glomerular filtration rate and renal plasma flow decrease by
30% to 40% compared with normal pregnancy of the same
duration (18,19). In our work, renal function at the beginning
of the study was of 96.9 ml/min which decreased to 93.8
ml/min at the end, detecting higher renal impairment related
to higher diastolic blood pressure and proteinuria, in
primiparous women with early beginning of preeclampsia, in
fact, one patient did not return to normal creatinine clearance
that could be a rare case of prolonged renal hypoperfusion
with resulting “acute tubular necrosis” (17). Anyway, if we
analyze by comparing the clinical and laboratory findings of
the seven uncontrolled women at the end of the study with
the 14 controlled we didn´t find significative statistical
difference (the lowest p was of 0.09 with systolic as well as
diastolic blood pressure comparing both groups) using
nonparametric tests due to the low number of preeclamptic
women.
The importance of following up primigravids with early
beginning of preeclampsia, high diastolic blood pressure and
proteinuria, after childbirth, is crucial for prognosis,
repercussion in antihypertensive treatment duration and
because this last factor implication towards renal function.
Also, this knowledge can help in planning new pregnancies,
since repetition of preeclampsia has been seen in the
subsequent ones, with the risk of permanent arterial
hypertension. Previous works suggest the hypothesis of
positive correlation between creatinine clearance and
endotheline, as has been shown by endothelium cell damage
(1,16), proving that patients with severe preeclampsia have
high incidence of chronic hypertension in a range from 1 to
11 years after delivery, and thus it is important to have
clinical follow up for a longer time.
Based on the results of our study we conclude the following
:
Preeclampsia was more common in primiparous1.
young women.
The severity of increment in levels of diastolic2.
blood pressure was related to the decrease in final
creatinine clearnance.
Decrease in serum albumin, higher severity of 243.
hrs proteinuria and longer duration of hypertension
was observed in those women who presented with
higher diastolic blood pressure at the beginning
and end of the study.
In those women with less pregnancies, it was4.
observed that there were longer duration of
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hypertension and higher intensity of proteinuria.
At earlier age of preeclampsia diagnosis, higher5.
severity of hypertension was observed.
Vigilance of arterial hypertension and renal function as well
as their early treatment can avoid the progression to renal
damage and subsequent chronic arterial hypertension in
preeclamptic women.
Because dysregulation of the maternal immune response to
pregnancy may play an important role in the cause of
complicated pregnancies (20), it is very important for future
basic and clinical research to look for medical alternatives to
prevent this disease.
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